Kasai H, Yamashita A, Akaike Y, Tanaka T, Matsuura Y, Moriishi K
mBio. 2024; 15(11):e0169124.
PMID: 39329491
PMC: 11559043.
DOI: 10.1128/mbio.01691-24.
Sumii Y, Kondo T, Ikegawa S, Fukumi T, Iwamoto M, Nishimura M
JCI Insight. 2023; 8(8).
PMID: 37092551
PMC: 10243810.
DOI: 10.1172/jci.insight.162180.
Chua B, Lennan C, Sunshine M, Dreifke D, Chawla A, Bennett E
Cell Stem Cell. 2023; 30(4):460-472.e6.
PMID: 36948186
PMC: 10164413.
DOI: 10.1016/j.stem.2023.02.010.
Worthington A, Cool T, Poscablo D, Hussaini A, Beaudin A, Forsberg E
Development. 2022; 149(8).
PMID: 35072209
PMC: 8917444.
DOI: 10.1242/dev.200139.
Huang J, Long Z, Jia R, Wang M, Zhu D, Liu M
Front Immunol. 2021; 12:680442.
PMID: 34956167
PMC: 8702497.
DOI: 10.3389/fimmu.2021.680442.
Role of B Cells in Responses to Checkpoint Blockade Immunotherapy and Overall Survival of Cancer Patients.
Kim S, Sumner W, Miyauchi S, Cohen E, Califano J, Sharabi A
Clin Cancer Res. 2021; 27(22):6075-6082.
PMID: 34230025
PMC: 8976464.
DOI: 10.1158/1078-0432.CCR-21-0697.
Induction of HOX Genes by Hepatitis C Virus Infection via Impairment of Histone H2A Monoubiquitination.
Kasai H, Mochizuki K, Tanaka T, Yamashita A, Matsuura Y, Moriishi K
J Virol. 2020; 95(6).
PMID: 33328315
PMC: 8094938.
DOI: 10.1128/JVI.01784-20.
Dynamical modeling predicts an inflammation-inducible CXCR7+ B cell precursor with potential implications in lymphoid blockage pathologies.
Enciso J, Mendoza L, Alvarez-Buylla E, Pelayo R
PeerJ. 2020; 8:e9902.
PMID: 33062419
PMC: 7531334.
DOI: 10.7717/peerj.9902.
Control of Early B Cell Development by the RNA N-Methyladenosine Methylation.
Zheng Z, Zhang L, Cui X, Yu X, Hsu P, Lyu R
Cell Rep. 2020; 31(13):107819.
PMID: 32610122
PMC: 7371152.
DOI: 10.1016/j.celrep.2020.107819.
The Tetraspanin CD53 Regulates Early B Cell Development by Promoting IL-7R Signaling.
Greenberg Z, Monlish D, Bartnett R, Yang Y, Shen G, Li W
J Immunol. 2019; 204(1):58-67.
PMID: 31748347
PMC: 6926393.
DOI: 10.4049/jimmunol.1900539.
Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD.
Kolupaev O, Dant T, Bommiasamy H, Bruce D, Fowler K, Tilley S
Blood Adv. 2018; 2(18):2307-2319.
PMID: 30228128
PMC: 6156893.
DOI: 10.1182/bloodadvances.2017014977.
Identification of an Essential Cytoplasmic Region of Interleukin-7 Receptor α Subunit in B-Cell Development.
Kasai H, Kuwabara T, Matsui Y, Nakajima K, Kondo M
Int J Mol Sci. 2018; 19(9).
PMID: 30149646
PMC: 6165445.
DOI: 10.3390/ijms19092522.
Regulation of B-lineage cells by caspase 6.
Watanabe C, Shu G, Giltiay N, Clark E
Immunol Cell Biol. 2018; 96(10):1072-1082.
PMID: 29863787
PMC: 6814014.
DOI: 10.1111/imcb.12172.
A defined metabolic state in pre B cells governs B-cell development and is counterbalanced by Swiprosin-2/EFhd1.
Stein M, Dutting S, Mougiakakos D, Bosl M, Fritsch K, Reimer D
Cell Death Differ. 2017; 24(7):1239-1252.
PMID: 28524857
PMC: 5520169.
DOI: 10.1038/cdd.2017.52.
Camel whey protein improves lymphocyte function and protects against diabetes in the offspring of diabetic mouse dams.
Mahmoud M, Badr G, El Shinnawy N
Int J Immunopathol Pharmacol. 2016; 29(4):632-646.
PMID: 27694615
PMC: 5806827.
DOI: 10.1177/0394632016671729.
Hematopoiesis and T-cell specification as a model developmental system.
Rothenberg E, Kueh H, Yui M, Zhang J
Immunol Rev. 2016; 271(1):72-97.
PMID: 27088908
PMC: 4837658.
DOI: 10.1111/imr.12417.
Oral supplementation of diabetic mice with propolis restores the proliferation capacity and chemotaxis of B and T lymphocytes towards CCL21 and CXCL12 by modulating the lipid profile, the pro-inflammatory cytokine levels and oxidative stress.
Al Ghamdi A, Badr G, Hozzein W, Allam A, Al-Waili N, Al-Wadaan M
BMC Immunol. 2015; 16:54.
PMID: 26370805
PMC: 4570673.
DOI: 10.1186/s12865-015-0117-9.
ADAM17 limits the expression of CSF1R on murine hematopoietic progenitors.
Becker A, Walcheck B, Bhattacharya D
Exp Hematol. 2014; 43(1):44-52.e1-3.
PMID: 25308957
PMC: 4268392.
DOI: 10.1016/j.exphem.2014.10.001.
Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.
Varzaneh F, Keller B, Unger S, Aghamohammadi A, Warnatz K, Rezaei N
J Clin Immunol. 2014; 34(5):524-43.
PMID: 24827633
DOI: 10.1007/s10875-014-0053-0.
Human lymphoid development in the absence of common γ-chain receptor signaling.
Kohn L, Seet C, Scholes J, Codrea F, Chan R, Zaidi-Merchant S
J Immunol. 2014; 192(11):5050-8.
PMID: 24771849
PMC: 4052377.
DOI: 10.4049/jimmunol.1303496.